Edwards Lifesciences Research and Development Expenses 2010-2024 | EW

Edwards Lifesciences annual/quarterly research and development expenses history and growth rate from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
  • Edwards Lifesciences research and development expenses for the quarter ending September 30, 2024 were $0.253B, a 6.25% decline year-over-year.
  • Edwards Lifesciences research and development expenses for the twelve months ending September 30, 2024 were $1.108B, a 9.97% increase year-over-year.
  • Edwards Lifesciences annual research and development expenses for 2023 were $1.072B, a 13.39% increase from 2022.
  • Edwards Lifesciences annual research and development expenses for 2022 were $0.945B, a 4.66% increase from 2021.
  • Edwards Lifesciences annual research and development expenses for 2021 were $0.903B, a 18.72% increase from 2020.
Edwards Lifesciences Annual Research and Development Expenses
(Millions of US $)
2023 $1,072
2022 $945
2021 $903
2020 $761
2019 $753
2018 $622
2017 $553
2016 $442
2015 $383
2014 $347
2013 $323
2012 $291
2011 $246
2010 $204
2009 $176
Edwards Lifesciences Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $253
2024-06-30 $273
2024-03-31 $285
2023-12-31 $297
2023-09-30 $270
2023-06-30 $244
2023-03-31 $261
2022-12-31 $232
2022-09-30 $234
2022-06-30 $251
2022-03-31 $229
2021-12-31 $233
2021-09-30 $238
2021-06-30 $225
2021-03-31 $207
2020-12-31 $196
2020-09-30 $196
2020-06-30 $182
2020-03-31 $187
2019-12-31 $194
2019-09-30 $196
2019-06-30 $192
2019-03-31 $171
2018-12-31 $163
2018-09-30 $162
2018-06-30 $154
2018-03-31 $143
2017-12-31 $147
2017-09-30 $143
2017-06-30 $134
2017-03-31 $129
2016-12-31 $115
2016-09-30 $113
2016-06-30 $113
2016-03-31 $102
2015-12-31 $98
2015-09-30 $101
2015-06-30 $98
2015-03-31 $86
2014-12-31 $84
2014-09-30 $88
2014-06-30 $89
2014-03-31 $86
2013-12-31 $79
2013-09-30 $84
2013-06-30 $81
2013-03-31 $80
2012-12-31 $75
2012-09-30 $74
2012-06-30 $74
2012-03-31 $69
2011-12-31 $61
2011-09-30 $62
2011-06-30 $65
2011-03-31 $59
2010-12-31 $56
2010-09-30 $53
2010-06-30 $51
2010-03-31 $45
2009-12-31 $88
2009-09-30 $45
2009-06-30 $43
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.608B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $214.078B 26.12
Intuitive Surgical (ISRG) United States $183.628B 96.01
Alcon (ALC) Switzerland $45.117B 31.76
IQVIA Holdings (IQV) United States $40.157B 22.12
IDEXX Laboratories (IDXX) United States $34.672B 40.83
DexCom (DXCM) United States $26.799B 40.36
Waters (WAT) United States $22.960B 33.95
STERIS (STE) Ireland $22.437B 25.85
SONOVA HOLDING (SONVY) Switzerland $21.922B 0.00
Hologic (HOLX) United States $18.696B 19.73
Fresenius Medical Care AG KGaA (FMS) Germany $12.376B 12.70
Sysmex ADR (SSMXY) Japan $11.851B 37.16
Globus Medical (GMED) United States $11.200B 28.52
Teleflex (TFX) United States $9.378B 14.96
Penumbra (PEN) United States $8.969B 87.86
Masimo (MASI) United States $8.917B 43.43
Glaukos (GKOS) United States $7.755B 0.00
PROCEPT BioRobotics (PRCT) United States $5.126B 0.00
Integer Holdings (ITGR) United States $4.542B 25.75
Inari Medical (NARI) United States $3.119B 0.00
TransMedics (TMDX) United States $2.898B 91.86
LivaNova (LIVN) United Kingdom $2.829B 16.33
Veracyte (VCYT) United States $2.811B 85.09
Nihon Kohden (NHNKY) Japan $2.519B 15.68
Tandem Diabetes Care (TNDM) United States $2.242B 0.00
Elekta AB (EKTAY) Sweden $2.227B 18.14
Integra LifeSciences Holdings (IART) United States $2.060B 10.77
RxSight (RXST) United States $2.024B 0.00
Alphatec Holdings (ATEC) United States $1.257B 0.00
Artivion (AORT) United States $1.233B 113.23
Pulse Biosciences (PLSE) United States $1.110B 0.00
OPKO Health (OPK) United States $1.025B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.963B 16.37
OrthoPediatrics (KIDS) United States $0.749B 0.00
Mesa Laboratories (MLAB) United States $0.726B 18.33
Pacific Biosciences Of California (PACB) United States $0.722B 0.00
IRadimed (IRMD) United States $0.712B 38.49
ORTHOFIX MEDICAL INC (OFIX) United States $0.702B 0.00
AxoGen (AXGN) United States $0.672B 0.00
SiBone (SIBN) United States $0.669B 0.00
Paragon 28 (FNA) United States $0.605B 0.00
Treace Medical Concepts (TMCI) United States $0.485B 0.00
CVRx (CVRX) United States $0.374B 0.00
ClearPoint Neuro (CLPT) United States $0.369B 0.00
Tactile Systems Technology (TCMD) United States $0.351B 18.99
Delcath Systems (DCTH) United States $0.304B 0.00
AngioDynamics (ANGO) United States $0.301B 0.00
Semler Scientific (SMLR) United States $0.291B 19.57
Sight Sciences (SGHT) United States $0.257B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
Inogen (INGN) United States $0.227B 0.00
Nevro (NVRO) United States $0.216B 0.00
Accuray (ARAY) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.186B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
908 Devices (MASS) United States $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.129B 0.00
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.110B 16.32
EDAP TMS S.A (EDAP) France $0.105B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.077B 0.00
Hyperfine (HYPR) United States $0.070B 0.00
LENSAR (LNSR) United States $0.068B 0.00
Covalon Technologies (CVALF) Canada $0.068B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.051B 0.00
Rapid Micro Biosystems (RPID) United States $0.049B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Vicarious Surgical (RBOT) United States $0.046B 0.00
Envoy Medical (COCH) United States $0.038B 0.00
Neuronetics (STIM) United States $0.036B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Precision Optics (POCI) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.028B 0.00
Biosig Technologies (BSGM) United States $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.020B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
QT Imaging Holdings (QTI) United States $0.012B 0.00
Pixie Dust Technologies (PXDT) Japan $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Check-Cap (CHEK) Israel $0.007B 0.00
ENDRA Life Sciences (NDRA) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00